Is laser treatment or surgery the best way of treating varicose veins?
ISRCTN | ISRCTN99270116 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN99270116 |
Secondary identifying numbers | VS03/2281 |
- Submission date
- 11/06/2007
- Registration date
- 10/07/2007
- Last edited
- 19/03/2008
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English Summary
Not provided at time of registration
Contact information
Mr Michael Gough
Scientific
Scientific
Leeds Vascular Institute
The General Infirmary at Leeds
Great George Street
Leeds
LS1 3EX
United Kingdom
Study information
Study design | Parallel group, non-blinded, randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | |
Study hypothesis | Endovenous laser ablation (EVLA) produces comparable short-term results to surgery (abolition of great saphenous vein [GSV] reflux and improvement in symptoms) for the treatment of primary varicose veins due to sapheno-femoral incompetence with greater saphenous vein reflux. |
Ethics approval(s) | Received from Leeds (West) Research Ethics Committee in May 2003 (ref: 03/052). |
Condition | Varicose veins |
Intervention | Endovenous laser treatment (810 nm diode laser, Diomed) versus sapheno-femoral ligation, greater saphenous vein stripping and avulsions (surgery). |
Intervention type | Other |
Primary outcome measure | 1. Abolition of GSV reflux at three months (duplex ultrasound) 2. Improvement in disease-specific quality of life (Aberdeen Varicose Vein Questionnaire) |
Secondary outcome measures | 1. Time to return to work and to normal activity 2. Pain and analgesia use during first week following treatment 3. Overall satisfaction and satisfaction with cosmetic outcome 4. Generic quality of life (36-item Short Form health survey [SF-36]) at 1 and 12 weeks following treatment 5. Complications |
Overall study start date | 05/06/2003 |
Overall study end date | 01/12/2006 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | 342 |
Participant inclusion criteria | 1. Symptomatic varicose veins 2. Primary sapheno-femoral incompetence with greater saphenous vein reflux |
Participant exclusion criteria | 1. Unable to consent 2. Children (under 18 years) 3. Unfit for general anaesthesia 4. Recurrent varicose veins 5. Patients on long-term anticoagulation 6. Patients with anterior thigh branch of greater saphenous vein arising within 10 cm of groin and competent GSV distal to this |
Recruitment start date | 05/06/2003 |
Recruitment end date | 01/12/2006 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Leeds Vascular Institute
Leeds
LS1 3EX
United Kingdom
LS1 3EX
United Kingdom
Sponsor information
Leeds Teaching Hospitals NHS Trust (UK)
Hospital/treatment centre
Hospital/treatment centre
Leeds Vascular Institute
The General Infirmary at Leeds
Great George Street
Leeds
LS1 3EX
England
United Kingdom
Website | http://www.leedsteachinghospitals.com/ |
---|---|
https://ror.org/00v4dac24 |
Funders
Funder type
Government
Leeds Teaching Hospitals NHS Trust (UK)
No information available
Diomed Ltd (UK) - part of research fellow salary paid (£15,000 pa)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | Results | 01/03/2008 | Yes | No |